Targeting fibroblasts in immune mediated inflammatory diseases: a cellular basis for cure?

Clicks: 1
ID: 313877
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #94 of 202 articles by views in Lara D. Veeken

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 202 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Fibroblasts constitute a major component of our stroma, the supportive bedding in which our tissues reside. The introduction of advanced single cell technologies has greatly enhanced our appreciation of fibroblast heterogeneity in health and Immune Mediated Inflammatory Diseases (IMIDs). This heterogeneity correlates with their diverse functions; including providing architectural support, tissue identity, 'stromal memory' and regulating immune responses and fibrosis. In Rheumatoid arthritis (RA) fibroblasts contribute to both synovial inflammation and bone and cartilage damage, and in Inflammatory Bowel Disease (IBD) to loss of the epithelial barrier, intestinal inflammation, and the development of intestinal strictures and fistulae in Crohn's disease. Fibroblasts have also been associated with non-response to current biologic therapies in RA and IBD. Targeting pathogenic fibroblast populations using new therapeutic modalities such as Chimeric Antigen Receptor (CAR) T cell therapies may 'reset' the stroma back to health and give hope for cure in these debilitating IMIDs.
Reference Key
openalex_W7160930501 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mikalena Xenophontos, Fränze Progatzky, Christopher D Buckley
Journal Lara D. Veeken
Year 2026
DOI
10.1093/rheumatology/keag249
URL
https://doi.org/10.1093/rheumatology/keag249
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.